ELUT – elutia, inc. - class a (US:NASDAQ)
Stock Stats
News
Cardiac Resynchronization Therapy (CRT) Market Insights, Competitive Landscape and Market Forecast 2024-2030 [Yahoo! Finance]
Elutia Awarded Cardiac Rhythm Management Devices Agreement with Premier, Inc.
Elutia Inc. (NASDAQ: ELUT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $10.00 price target on the stock.
Elutia Inc (ELUT) Q3 2024 Earnings Call Highlights: Strategic Growth Amid Revenue Challenges [Yahoo! Finance]
Elutia Announces Strong Third Quarter Results, Accelerating Toward Full Launch of EluPro® Antibiotic-Eluting BioEnvelope in 2025 [Yahoo! Finance]
Form 4 ELUTIA INC. For: Dec 10 Filed by: Ferguson Matthew
Form 4 ELUTIA INC. For: Dec 10 Filed by: Mills C Randal
Form 4 ELUTIA INC. For: Dec 10 Filed by: Williams Michelle LeRoux
Form 10-Q ELUTIA INC. For: Sep 30
Form SCHEDULE 13G/A ELUTIA INC. Filed by: Nantahala Capital Management, LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.